TAIWAN · TWSE / TPEx
ARICH
久裕 · 4173 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$17.801 month +4.1% · 1 year -25.6%
Directors and supervisors hold29,833,28040.0% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold29,829,74240.0% of shares issued
Revenue, 2026-09+42.1%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 佳醫健康事業股份有限公司 | Chairman · Director · Major shareholder (10%+) | 29,829,742 | 29,829,742 | 40.00% | — | — |
| 張明正 | Chairman (corporate representative) | — | 0 | — | — | — |
| 周臣孝 | Director (corporate representative) | — | 0 | — | — | — |
| 張憲政 | Director (corporate representative) | — | 0 | — | — | — |
| 佳儀投資股份有限公司 | Director | 1,538 | 1,538 | 0.00% | — | — |
| 薛福全 | Director (corporate representative) | — | 30,768 | 0.04% | — | — |
| 傅若軒 | Director | — | 0 | — | — | — |
| 軒輝投資股份有限公司 | Director | 2,000 | 2,000 | 0.00% | — | — |
| 蘇文琳 | Director (corporate representative) | — | 0 | — | — | — |
| 董德泰 | Independent director | — | 0 | — | — | — |
| 徐水盛 | Independent director | — | 0 | — | — | — |
| 王昌勝 | Independent director | — | 0 | — | — | — |
| 洪文銓 | President | — | 0 | — | — | — |
| 林怡 | Chief financial officer · Chief accountant | — | 0 | — | — | — |